Leachman SA, Carucci J, Kohlmann,
Banks KC, et al. Selection criteria for genetic assessment of patients with familial melanoma.
Journal of the American Academy of Dermatology
2009;61(4):677.e1-14.
Leong SP, Accortt, NA, Essner R, Ross M, Gershenwald JE, Pockaj B, Hoekstra HJ, Garberoglio C, White RL, Chu DZJ, Biel M,
Charney K
,
et al. Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients for the sentinel lymph node working group. Archives Otolaryngol Head Neck Surg. 2006;132:370-373.
Goodman MM,McCullough JL. Human melanoma in cyclosporine-immunosuppressed rats.
Models in Dermatology, Maiback, H.; Lowe, N. (eds), Basel, Switzerland: Karger, S., Vol. 4, 249-252, 1989.
Goodman MM, McCullough JL, Biren CA, Barr RJ. A model of human melanoma in cyclosporine-immunosuppressed rats;
Journal of Investigative Dermatology 1987;88(2):141-144.